Physics and AI Driven Precision Engineering of Novel Drugs

Health + Time : Priceless

We Engineer New Treatments Atom by Atom

To help you live healthier, longer

First-in-Class Drug Candidates to Change the Standard of Care for Every Disease We Address
More about our pipeline
Recent News
Our stories
Verseon: Combining Deep Quantum Modeling™ and AI to Find Breakthrough Drugs
Verseon’s CEO Adityo Prakash discusses the role of the company’s Deep Quantum Modeling™ of protein-drug interactions with Pharmaceutical Executive’s Mike Hollan
April 14, 2025
VersAI's Unique Neural Network Architecture Marks a Major Leap Forward for Drug Discovery AI
Drug Discovery World's editor Reece Armstrong and Verseon's CEO Adityo Prakash discuss the implications of different AI neural network architectures for drug discovery
March 25, 2025
VersAI is More Accurate and Orders of Magnitude Faster than Google's AutoML
Verseon is challenging the dominance of deep learning—especially in areas where data is scarce
February 9, 2025
A Pharma Company (Really?) Leading the Way in AI Innovation? Yes, Really!
Using a novel "network of networks" neural architecture, VersAI™ trains models 3,000 times faster than Google AutoML on standard benchmark datasets
January 21, 2025
From Months to Minutes: VersAI™ Sets New Standard for AI Training Speed
Verseon's novel general-purpose AI technology shows dramatically faster training speeds compared to Deep Learning technologies like Google's AutoML
December 19, 2024
How Organoids Will Impact Medicine
Verseon's Head of Discovery Biology Anirban Datta discusses how recent breakthroughs are bringing once-distant possibilities for drug discovery and restoration of organ function closer to reality
October 30, 2024
How Verseon's AI Overcomes Data Scarcity to Transform Medicine
Verseon's newly developed AI technology, VersAI™, elevates AI accuracy in drug discovery - even with sparse data
October 29, 2024
Forbes Highlights Verseon's Platform to Design Novel Drugs No One Else Can
"Verseon's disruptive platform changes how drugs can be discovered and developed, and the company is poised to make a dramatic impact on modern medicine."
October 22, 2024
Verseon: Combining Deep Quantum Modeling™ and AI to Find Breakthrough Drugs
Verseon’s CEO Adityo Prakash discusses the role of the company’s Deep Quantum Modeling™ of protein-drug interactions with Pharmaceutical Executive’s Mike Hollan
April 14, 2025
VersAI's Unique Neural Network Architecture Marks a Major Leap Forward for Drug Discovery AI
Drug Discovery World's editor Reece Armstrong and Verseon's CEO Adityo Prakash discuss the implications of different AI neural network architectures for drug discovery
March 25, 2025
VersAI is More Accurate and Orders of Magnitude Faster than Google's AutoML
Verseon is challenging the dominance of deep learning—especially in areas where data is scarce
February 9, 2025
A Pharma Company (Really?) Leading the Way in AI Innovation? Yes, Really!
Using a novel "network of networks" neural architecture, VersAI™ trains models 3,000 times faster than Google AutoML on standard benchmark datasets
January 21, 2025
From Months to Minutes: VersAI™ Sets New Standard for AI Training Speed
Verseon's novel general-purpose AI technology shows dramatically faster training speeds compared to Deep Learning technologies like Google's AutoML
December 19, 2024
How Organoids Will Impact Medicine
Verseon's Head of Discovery Biology Anirban Datta discusses how recent breakthroughs are bringing once-distant possibilities for drug discovery and restoration of organ function closer to reality
October 30, 2024
How Verseon's AI Overcomes Data Scarcity to Transform Medicine
Verseon's newly developed AI technology, VersAI™, elevates AI accuracy in drug discovery - even with sparse data
October 29, 2024
Forbes Highlights Verseon's Platform to Design Novel Drugs No One Else Can
"Verseon's disruptive platform changes how drugs can be discovered and developed, and the company is poised to make a dramatic impact on modern medicine."
October 22, 2024
More News
Changing everything the world can expect from 21st Century Medicine
Continue to Company